Occult intestinal angiosarcoma presenting as refractory anemia during tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A case report

Table 2 Chronological summary of clinical events following diagnosis

Date	Event	Details/findings
January 2025	Neurological deterioration	Brain MRI: Numerous new hemorrhagic intra-axial masses in supratentorial and infratentorial regions
February 2025 to March 2025	Brain radiotherapy	3D conformal IGRT was well-tolerated
March 2025 to January 2025	Systemic therapy	Weekly paclitaxel, Bevacizumab was not added owing to the patient’s ongoing and recurrent bleeding risk
Follow-up	Disease progression	Thoracic CT scan: Extensive new pulmonary nodules; new pleural nodular involvement
Final decline	Clinical deterioration	Rapid thoracic disease progression despite ongoing management
Death	Cause of death	Uncontrolled thoracic hemorrhage before initiation of further therapy

MRI: Magnetic resonance imaging; IGRT: Image-guided radiotherapy; CT: Computed tomography.